Graphique du cours de l'action IKT
IKT Dividendes
Inhibikase Therapeutics Inc
$2.33
-3.31%
$-0.08
À la fermeture : Sep 10, 16:00:00 GMT-4
$2.33
0%
$0
Post-Marché: Sep 10, 20:00:00 GMT-4
Retour
Inhibikase Therapeutics Inc (IKT) Dividendes
Statistiques clés
Clôture préc.
$2.41
Prix d'ouverture
$2.37
Plage de la journée
$2.32 - $2.37
Plage de 52 semaines
$1.33 - $2.61
Volume
332.3K
Volume moyen
737.2K
Rendement en dividend
--
BPA (TTM)
-0.50
Capitalisation boursière
$365.8M
Qu’est-ce que IKT ?
Inhibikase Therapeutics, Inc. is a clinical-stage pharmaceutical company, which engages in development of protein kinase inhibitor therapeutics to modify the course of Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. The company is headquartered in Wilmington, Delaware and currently employs 35 full-time employees. The company went IPO on 2020-12-23. The firm is focused on developing Abelson Tyrosine Kinase inhibitor therapeutics for cardiopulmonary disease. The Company’s multi-therapeutic pipeline includes IKT-001, a prodrug of imatinib mesylate, for pulmonary arterial hypertension (PAH).
Fonctionnalités
© 2026 Edgen fonctionné par
